Table 1.
Clinical features of patients.
| HD | PS | GD | SpA | RA | |
|---|---|---|---|---|---|
| n | 38 | 15 | 8 | 15 | 14 |
| Gender (Female) | 26 | 9 | 8 | 7 | 10 |
| Age (years) | 48.6 (33.8–62.5) | 37 (31.1–50.8) | 57.8 (57.1–58.4) | 45.3 (28.3–51.7) | 60.7 (47.2–74.9) |
| Disease Duration (months) | 5.5 (3.4–6.9) | 20 (18–24) | 74.9 (40–125.8) | 75.3 (32.9–176.7) | |
| Response to treatment (%) | |||||
| No responder | 5.2 | 28 | 6.9 | 7.1 | |
| Intermediate responder | 5.3 | 28 | 20.7 | 28.6 | |
| Responder | 89.5 | 44 | 72.4 | 64.2 |
Values show number for categorical values and median (25–75 interquartile intervals) for continuous variables. HD: healthy donors; PS: psoriasis; GD: Graves´ disease; SpA: pondyloarthritis; RA: rheumatoid arthritis.